The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

A nutrition expert has raised concerns as studies show a staggering number of people lack a key mineral crucial for disease prevention and maintaining a healthy nervous system, bones, teeth, and ...

Lars von Trier has been admitted to a care center to receive treatment for Parkinson's disease, his production company confirms.

The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Lars Von Trier is a Danish film director and screenwriter. Trier has been the subject of criticism and controversies amidst his statements on touchy political subjects. In 2023, the filmmaker was ...

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

HIV is a manageable chronic condition. With treatment, people living with HIV can have long and healthy lives. However, if left untreated, it can cause a weakened immune system or acquired immune ...

Now, scientists in Korea have discovered that the Parkinson’s disease drug procyclidine can alleviate physical symptoms of ...

The Oklahoma Medical Research Foundation has received a $3 million grant to study Parkinson's disease, potentially leading to ...

By creating a new metric, researchers envision the possibility of diagnostic and treatment advances for the disease, which is estimated to affect about 4 million people worldwide.